chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At 114, patient reported feeling light headed to  EMT. EMT assessed patient vitals: blood pressure (unable to obtain blood pressure), SpO2 94%, and pulse 54 beats/minute. Patient given water and rested head on mother's shoulder. Patient reported no difficulty breathing/itchiness/hives/rashes. Patient reported history of eosinophilic esophagitis. Patient reassessed at 1120. Patient vitals were blood pressure (unable to obtain), SpO2 96% and pulse 96 beats/minute. Patient reassessed at 1140. Patient vitals were blood pressure 96/80 mmHg, SpO2 100% and pulse 90 beats/minute. Patient stated she felt a lot better. Lead nurse educated patient on following up with primary care provider, signing up on v-safe, and signs/symptoms of when to seek emergency care.
Whelps all over; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No medical history information reported .     On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced URTICARIA. The patient was treated with BENADRYL for Urticaria, at an unspecified dose and frequency and ZYRTEC for Urticaria, at an unspecified dose and frequency. At the time of the report, URTICARIA had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported  In the follow up it was reported that patient had 2nd dose, still on Benadryl. PCP recommended reporter to see an allergist and needs a list of ingredients.    Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Second dose details updated, event outcome updated
aches; chills; upset stomach; fatigue; temperature 100.5; it feels like i have covid; This spontaneous case was reported by a nurse and describes the occurrence of MYALGIA (aches), CHILLS (chills), ABDOMINAL DISCOMFORT (upset stomach), FATIGUE (fatigue) and PYREXIA (temperature 100.5) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (aches), CHILLS (chills), ABDOMINAL DISCOMFORT (upset stomach), FATIGUE (fatigue), PYREXIA (temperature 100.5) and COVID-19 (it feels like i have covid). At the time of the report, MYALGIA (aches), CHILLS (chills), ABDOMINAL DISCOMFORT (upset stomach), FATIGUE (fatigue), PYREXIA (temperature 100.5) and COVID-19 (it feels like i have covid) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.
death  - TIA (transient ischemic attack)  - Cerebrovascular accident (CVA), unspecified mechanism (CMS/HCC)
COVID-19 testing positive.  Chest x-ray reported no significant change compared to 07/2016
Red/raised area around site, warm to the touch, difficulty breathing. Went to PCP.
a stye on his eye; This is a spontaneous report from a contactable physician reported for self. This male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on Jan2021 at single dose for covid-19 immunisation. Scheduled for their second doses of Pfizer-Biontech Covid19 vaccine on 01Feb2021. Scheduled for their second doses of Pfizer-Biontech Covid19 vaccine on 01Feb2021. He developed a stye on his eye in Jan2021 after his first dose of Covid19 vaccine- unrelated, and has been treating it with antibiotic and steroid eye drops, but MD has prescribed him oral doxycycline. Outcome of the event was unknown.  Information on the Lot/Batch Number has been requested.; Sender's Comments: In concurrence with the reporting physician, the Company deems the reported stye an inter-current disease, unrelated to the COVID-19 vaccine, BNT162B2.
Pt. states that after receiving the 3rd dose Booster of Moderna 09/30/2021, started experiencing symptoms 09/30/2021 of fever (103.0), Chills, nausea, vomiting, dry cough, congested, loss of appetite, and fatigue. No noted Primary visit. Still continuing to experience fatigue and loss of appetite.
This spontaneous report as received from a healthcare professional via a company representative refers to her son of an unknown age. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with the second shot in the human papillomavirus vaccination series with an unidentified Merck hpv vaccine (it was unknown if it was GARDASIL or GARDASIL 9, lot number was not provided). The reporter stated that when the patient was about to get the unidentified Merck hpv vaccine, the nurse that was administering stated that it may hurt more than other vaccinations because it contains more protein. On an unknown date, at an unspecified time after administration of unidentified Merck hpv vaccine, the patient reported pain at the injection site that lasted for an unspecified amount of time. The patient was fully recovered from the adverse event on an unknown date. The relatedness between the adverse event and unidentified Merck hpv vaccine was not provided. Additional information has been requested.
Patient developed a painful and itchy rash on her truck 4 days after being immunized for Shingles.
First day after my first vaccine I experienced feeling light headed. The morning of the second day after my first vaccine I experienced in the early morning nausea and vomiting x2. I felt continuous nausea for 2 days along with body aches and tiredness.  I continued to have light headed feelings in the morning when first getting up for the next few days.  I contacted my nephrologist and notified her of my reaction to the vaccine. She was concerned about my issue of vomiting thus my decision to advise you of my reaction. Please advise if I should take the second Moderna vaccine I have scheduled for July 7, 2021. Thank you.
Excessive tiredness, new mild uncontrolled jerking while sleeping, appetite decreased. Congestion, running nose and excessive fussiness started later that evening. 03/03/2016 at 3:00 PM a mild increase in temperature was noted (99.5), by 7:00 PM temperature had risen to 100.7, Tylenol given but baby threw that up within 10 minutes. Cool wash cloth applied to forehead and back of neck. At 3 am, baby woke up with a temperature of 101.3. Last temperature was 101.6 taken at 8:00 am on 03/04/2016. Still throwing up all Tylenol, refuses food and water but will nurse on and off.
Contracted COVID -19 post first dose of Pfizer inoculation, sob, hypoxic on room air at 87%, elevated d-dimer, elevated CRP
Sore shoulder; This is a spontaneous report from a contactable consumer (patient) received via medical information team. A 73-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EL1283), via an unspecified route of administration on 12Jan2021 (at an age of 73-years-old) at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. She got her first dose on 12Jan2021 at the center (City name withheld) and scheduled to come back for her second dose 4 weeks after receiving her first dose. The appointment for 4 weeks out was already made for 09Feb2021, states she did not know who to call to change it. Upon follow up on 08Feb2021, patient reported that when she originally scheduled her appt. online, she was told that she would get moderna and follow up appt. in 4 weeks. When she ended up getting Pfizer, she tried to change her appt. to 3 weeks, but she was not able to. She called the county and was told it would be ok to have it at 4 weeks per their epidemiologist. She had no side effects other than a sore shoulder that night. Patient was not admitted to the hospital due to the event. No treatment was received for the event. The outcome of the event sore shoulder was unknown.  Upon Follow-up (08Feb2021): New information received from a contactable consumer. This consumer reported in response to Non-HCP letter sent which included: patient details (age group: adult, weight: 123 lb, height: 5 feet, 2 inches), new event (sore shoulder), treatment and clinical information.  No follow-up attempts are possible. No further information is expected.
HAVING A REACTION TO COVID VACCINE; NOT FEELING WELL; This spontaneous case was reported by a physician and describes the occurrence of MALAISE (NOT FEELING WELL) and VACCINATION COMPLICATION (HAVING A REACTION TO COVID VACCINE) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB for Crohn's disease.    No Medical History Information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (Intramuscular) at an unspecified dose. On 04-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MALAISE (NOT FEELING WELL). On an unknown date, the patient experienced VACCINATION COMPLICATION (HAVING A REACTION TO COVID VACCINE). At the time of the report, MALAISE (NOT FEELING WELL) and VACCINATION COMPLICATION (HAVING A REACTION TO COVID VACCINE) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was provided by the reporter.  No treatment medications was provided by the reporter This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-Jun-2021 and was forwarded to Moderna on 11-Jun-2021.    This spontaneous case was reported by a physician and describes the occurrence of MALAISE (NOT FEELING WELL) and VACCINATION COMPLICATION (HAVING A REACTION TO COVID VACCINE) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB for Crohn's disease.    No Medical History Information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (Intramuscular) at an unspecified dose. On 04-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MALAISE (NOT FEELING WELL). On an unknown date, the patient experienced VACCINATION COMPLICATION (HAVING A REACTION TO COVID VACCINE). At the time of the report, MALAISE (NOT FEELING WELL) and VACCINATION COMPLICATION (HAVING A REACTION TO COVID VACCINE) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was provided by the reporter.  No treatment medications was provided by the reporter
Attendee reported 'feel itchy everywhere', no other signs or symptoms; 50mg Benadryl given PO; then reported: "I feel fine now" 25 minutes later.
pt received 1st Gardasil injection and a few hours after injection reported symptoms of nausea, vomiting, hot flashes, abd cramping and diarrhea which subsided after a few hours.
Patient was pale, heart rate increased, fever, sluggish was taken to the ER and diagnosed with cellulitis in the arm.
Patient right arm warm, red and swollen. Pt running low grade fever. Pt called pharmacy 12/6 I advised pt to contact MD due to reaction. Pt visit dr and antibiotic ordered. Called pt 12/8, fever down still some redness/swelling.
Positive Covid Test on May 25, 2022. On May 23. Had what I thought was mild allergies. Slight headache, mild sore throat.  Sore throat only lasted 1 day.  Mild headache persisted for 4 days.  Start sneezing a lot on the 25th....unusual for me. Did Covid Test-positive.  Called doc. Prescribed Molnupiravir 200 mg, 4 capsules, 2x daily, for 5 days. Self isolated.  sneezing stopped but congested cough started.  Tired for 3 days.  5th day was much better.  Following Tuesday returned to work (with mask).   Cough was much less but continued.  Would start about 4 hours after rising and continue until mid day.  This lasted until about June 8th.  No other symptoms except cough.  Not tired. No brain fog.
pt received 2nd dose of her Covid vaccination on 4/8/2021. on 4/12/2021 Pt noted itching in left deltoid region at site of injection with redness and warmth. (red area measured 4x 6 inches) Seen again in clinic 4/13/2021 and reddened area increased to 5x7 inches. pt c/o aching at site. area remains warm to touch.
Tingling in legs and feet; Hotness in feet; Weird nuisances; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in legs and feet), FEELING HOT (Hotness in feet) and FEELING ABNORMAL (Weird nuisances) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingling in legs and feet), FEELING HOT (Hotness in feet) and FEELING ABNORMAL (Weird nuisances). At the time of the report, PARAESTHESIA (Tingling in legs and feet), FEELING HOT (Hotness in feet) and FEELING ABNORMAL (Weird nuisances) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-057873 (Patient Link).
Patient presented to the ED for lower abdominal and upper pelvic pain within 6 weeks of receiving COVID vaccination.
no other AE's reported; temperature - 7.4 C / the VARIVAX was administered; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 19-FEB-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live VARIVAX 0.5 ml, lot # T021821, expiration date 25-JUN-2022 (route of administration and anatomical location were not provided) for prophylaxis. The administered vaccine was stored in a temperature of -7.4 degrees Celsius (C) for 3 hours and 54 minutes. No previous temperature excursion was reported. Digital data logger was involved.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-2102USA008721: US-009507513-2102USA008814:
A strong thrumming in left ear. Occurs indiscriminately throughout the day, every day. Some episodes are intense. Pulsating seems to mimic my heart and/or pulse rate.
About 4 hours after receiving the vaccine I started to have heart palpitations that lasted roughly 8 hours. During that time there were moments where I found myself confused and not sure what I was doing almost as if I was high. It would last a few minutes then I would come back to myself again.   Then, the next morning after receiving the vaccine I woke up to find I had vaginal bleeding.  I was not on my period so I should not have been bleeding. For the following 4 days, I experienced cramping pain.
No additional AE reported; dose of PROQUAD that experienced a temperautre excursion was administered to the patient; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies, drug reactions, allergies or medical history provided.  On 20-MAY-2022, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) subcutaneous injection, 0.5 ml, lot # U039262, expiration date 09-JUN-2023, for prophylaxis (anatomical site was not provided) (Product storage issue). The vaccine was improperly stored for 30 minutes in temperature of 7.3 F. Data logger was not used to capture temperature excursion. There was no previous temperature excursion. No additional adverse event was reported (No adverse event).; Sender's Comments:  US-009507513-2206USA007845: US-009507513-2206USA007839:
BLEEDING NOSE; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced bleeding nose. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of bleeding nose was not reported. This report was non-serious.
Having numbness and tingling in lower extremities since Tuesday as well. Reports no injury that she is aware of. Did have her Covid vaccine on Tuesday, not sure if the symptoms are related.)
Received FLUAD (65 +) at 3:00pm right deltoid; 4:18pm patient return to the flu clinic site complaining of feeling flush with a headache BP 163/92 HR 80 Resp 16 non labored, had her to lie down in bed with head elevated; took BP every 5 minutes; 4:24 pm she did not have a headache and no longer flush feeling BP 126/77 HR75; At 5:02 patient was standing and walking feeling "like my normal self now"; I walked patient to the car and let her take home the BP monitor to monitor over the weekend since doctor office was closed BP 164/96 at departure; Called patient at 7:30 pm BP was running 132-155/79-90; Told patient to call Dr.on Monday 9/11/2017;  I reported off to Dr. on 9/11/2017 at 9:30am (RN RPh.)
Pain at Injection Site; Low-grade fever; Nausea; Headache; Generalized Aches and Pain; Redness; pain down neck; flu-like symptoms; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 57-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of injection site pain (received 1st dose on 1st April 2019, refer case US2019127814).   On 12th July 2019, the patient received the 2nd dose of Shingrix .5 ml. In July 2019, less than a day after receiving Shingrix, the patient experienced injection site pain, low grade fever, nausea, headache, generalized aching, erythema, neck pain and influenza-like symptoms. The patient was treated with paracetamol (Tylenol) and ibuprofen (Advil). Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain, low grade fever, nausea, headache, generalized aching, erythema, neck pain and influenza-like symptoms were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, low grade fever, nausea, headache, generalized aching, erythema, neck pain and influenza-like symptoms to be related to Shingrix.  Additional information received were as follows: The caller reported that she received 1st and 2nd dose of Shingrix doses over a period of 3 months. Within about 6 to 8 hours following vaccination the patient experienced pain at injection site, redness, low grade fever, nausea, headache, generalized aches and pain down neck (flu-like symptoms). The patient reported that the current symptoms were not bad as 1st dose. The reporter consented to follow up reports taking Tylenol and Advil intermittently . This was 1 of the 2 cases reported by same reporter.
Today, March 16, 2021 is my 48th day waiting for my 2nd Pfizer Vaccination. I have checked the computer everyday and have completed a request appointment form 7 times I have spoken to several persons and cannot get an appointment at all anywhere. In reading all of the materials about the vaccination there is nothing about what to do or who to contact if more than 42 days go by from the first shot.
pt recvd vax 9JUL92 1PM & devel fever 104-105 not relieved by APAP; listless, not eating; devel rash macular-papular seen by MD who called it DTP rxn;
This spontaneous report received from a consumer via a company representative via social media concerned a female of unspecified age, race, and ethnic origin. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) dose, start therapy date were not reported, 1 total administered for prophylactic vaccination (Dose number in series 1). The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, reporter reported that "My great aunt's daughter also suffered the jab damage, blood clots in the brain massive stroke. She had not recovered. Unfortunately, they did not get the placebo or the saline jab, they got the actual experimental drug." The action taken with covid-19 vaccine was not applicable. The patient had not recovered from blood clots in brain and massive stroke. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20211260743 and 20211260953.; Sender's Comments: V0: 20211261168-covid-19 vaccine Blood clots in brain, massive stroke. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Breakthrough COVID-19 case with symptom onset 7/12/2021: chills, sore throat, cough, sob/difficulty breathing, headache, diarrhea, loss of smell/taste, tired. Hospitalized 7/19/2021-7/24/2021. ICU Admission.
on 3/25/21 I received my second shot. On April 26th I noticed a small spot of Allopecia Areatha. May 11th the spot grew to the size of a dime an I began to experience hair loss (200+ strands per day. June 20th we detected 5 spots of patchy baldness. By July my condition was no longer manageable and saw a dermatologist. I began steroid treatment, and completed two rounds with no results, I also began topical steroids and rogane with no results. Currently I am undergoing PRP Platelet rich plasma injections and have begun to see results with white regrowth. I have no history of Allopecia in my family and I have no history of hair loss.
2 hrs post infect pt suffered shakes, chills, syncope, nausea & mild elevated GPT; labs, EKG, supportive care & IVFs; later same day pt was released to recuperate @ home;
Pt. states that after receiving the 2nd dose of Phizer 03/16/2021, started experiencing symptoms of throat swelling, facial swelling, difficulty breathing. Transported to ER, treated with Benadryl and Prednisone. No other noted Symptoms, all symptoms have subsided. No Primary visit noted.